LPAAT-β inhibitors and uses thereof
US7199238B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2005 |
| Grant date | Apr 3, 2007 |
| Priority date | — |
| Expiry date | Sep 12, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D251/58
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to triazines and the use thereof to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity. The invention further relates to methods of treating cancer using said triazines. The invention also relates to methods for screening for LPAAT-β activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.